Neoadjuvant treatment (FOLFOX4 plus hypofractionated tomotherapy) for patients with locally advanced rectal cancer: a multicenter phase II trial.
Alessandro PassardiIlario Giovanni RapposelliEmanuela ScarpiElisa NeriElisabetta ParisiGiulia GhigiGiorgio ErcolaniAndrea AvanzoliniDavide CavaliereBritt RudnasMartina ValgiustiDomenico BaroneFabio FerroniGiovanni Luca FrassinetiAntonino RomeoPublished in: Therapeutic advances in medical oncology (2020)
ClinicalTrials.gov identifier: NCT02000050 (registration date: 26 November 2013) https://clinicaltrials.gov/ct2/show/NCT02000050.
Keyphrases
- rectal cancer
- locally advanced
- radiation therapy
- neoadjuvant chemotherapy
- phase ii study
- squamous cell carcinoma
- computed tomography
- dual energy
- randomized controlled trial
- magnetic resonance imaging
- cross sectional
- open label
- image quality
- clinical trial
- combination therapy
- small cell lung cancer
- positron emission tomography
- study protocol
- replacement therapy
- magnetic resonance
- pet ct